Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA6620
Max Phase: Preclinical
Molecular Formula: C12H16F3NO2
Molecular Weight: 263.26
Molecule Type: Small molecule
Associated Items:
ID: ALA6620
Max Phase: Preclinical
Molecular Formula: C12H16F3NO2
Molecular Weight: 263.26
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Racemic DOTFM
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(C(F)(F)F)c(OC)cc1CC(C)N
Standard InChI: InChI=1S/C12H16F3NO2/c1-7(16)4-8-5-11(18-3)9(12(13,14)15)6-10(8)17-2/h5-7H,4,16H2,1-3H3
Standard InChI Key: WPGOTSORDNBMHP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 263.26 | Molecular Weight (Monoisotopic): 263.1133 | AlogP: 2.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 44.48 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.90 | CX LogP: 2.37 | CX LogD: -0.03 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.91 | Np Likeness Score: -0.10 |
1. Chambers JJ, Kurrasch-Orbaugh DM, Parker MA, Nichols DE.. (2001) Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists., 44 (6): [PMID:11300881] [10.1021/jm000491y] |
2. Nichols DE, Frescas S, Marona-Lewicka D, Huang X, Roth BL, Gudelsky GA, Nash JF.. (1994) 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist., 37 (25): [PMID:7996545] [10.1021/jm00051a011] |
3. Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE.. (2005) Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling., 48 (7): [PMID:15801832] [10.1021/jm0493109] |
4. Parker MA, Kurrasch DM, Nichols DE.. (2008) The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands., 16 (8): [PMID:18296055] [10.1016/j.bmc.2008.02.033] |
Source(1):